Genmab — Januar 2019

[Bulder]

Det vil nok være det klogeste. Vi ved ikke med sikkerhed om der er en RTOR-proces. Heller ikke om den i så fald er FDA-forsinket. Så hvis alle indstiller sig på en normal PR med godkendelse i juli/august, kan vi kun bliver positivt overrasket.

[E_L]

safety study ofatumumab /MS started recruiting.
https://clinicaltrials.gov/ct2/history/NCT03650114?A=1&B=2&C=merged

[E_L]

how will this work? all Asclepios patients will roll into this trial automatically or something?

[E_L]

(shitty day for most european Healthcare & biotech by the way, not just Genmab)

[AaBforever]

yes..no celebrations today.

[nohope]

That calls for a Carlsberg.

[hjeasyconsult.dk]

probably true

[bibob]

Access denied | www.fiercebiotech.com used Cloudflare to restrict access | www.fiercebiotech.com | Cloudflare

(www.fiercebiotech.com)

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

Just a moment...

(www.proinvestor.com)

[polle1]

God morgen

[transalp]

Go morgen..

[bibob]

God morgen.

[Plimsoller]

God morgen

[E_L]

If the shutdown drags on at FDA, it will put anticipated new treatments in jeopardy https://www.statnews.com/2019/01/14/shutdown-impact-on-drug-approvals/

[AaBforever]

Trenden fortsætter.

[Nickstar]

desværre, men kommer vel heller ik bag på dig?

[Vitus]

Hvad er baggrunden for dit svar Nickstar ?

[JKY_VH]

The trend is your enemy, hedder det nu om stunder. Lad os nu se, hvordan det udvikler sig i dag:-)

[Bulder]

So far, the agency’s sizable coffer of leftover cash has ensured that the FDA can continue to review any drug applications submitted before the shutdown began. Janssen har formentlig indsendt de første data i november - hvis der kører RTOR.